ETR/NOT (ETR/NOT)

Deutsche Börse Xetra: ETR/NOT · EUR

€140

-0.44 (-0.3%)· Recorded snapshot

Market cap	264B
Revenue (ttm)	50.5B
Net income (ttm)	8.8B
EPS (ttm)	€4.72
P/E (trailing)	29.5x
P/E (forward)	16.1x
Dividend	€4.10 (2.94%)
Volume	5,873

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 50.5B
Net income (ttm): 8.8B
EPS (ttm): €4.72
P/E (trailing): 29.5x
P/E (forward): 16.1x
Market cap: 264B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E16.1

P25 13.5P50 19.1P75 28.3

Trailing P/E29.5

P25 14.1P50 23.7P75 38.5

ROE24.3

P25 -50.4P50 0.5P75 12

ROIC19.3

P25 -29.8P50 1.9P75 10.7

Benchmarks · 1M

All ETR/NOT indicators

Market & fundamental data

Available fields

249

Groups with data

Currency

USD

Showing 249 of 249 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Switzerland
Country code	DE
Earnings date	2026-10-27
Employees	75,267
Employees change	-616
Employees growth	-0.81%
Enterprise value	EUR 299.9B
Exchange	Deutsche Börse Xetra
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	1996
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	CH0012005267
Last earnings date	2026-10-27
Last refreshed	2026-10-28
Market cap	EUR 264B
Next earnings date	2027-02-03
Price	EUR 139.56
Price currency	EUR
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	etr/NOT
Website	https://www.novartis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	19.87x
Average P/E ratio (3Y)	17.62x
Average P/E ratio (5Y)	17.8x
Earnings yield	3.38%
EV/Earnings	33.95x
EV/EBIT	17.05x
EV/EBITDA	13.65x
EV/FCF	21.75x
EV/Sales	5.79x
FCF / EV yield	4.6%
FCF yield	5.22%
Forward P/E	16.12x
Graham number	43.00391
Graham upside	-69.28%
Lynch fair value	EUR 23.42
Lynch upside	-83.27%
P/(FCF - SBC) ratio	20.64x
P/(OCF - SBC) ratio	18.52x
P/B ratio	7.98x
P/E ratio	29.55x
P/FCF ratio	19.15x
P/OCF ratio	17.3x
P/S ratio	5.23x
Price/EBITDA ratio	12.46x
Sector forward P/E	14.8x
Sector P/E	39.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	33.98%
EBITDA margin	41.94%
Effective tax rate	20.8%
FCF margin	26.8%
Gross margin	75.21%
Operating margin	33.98%
Pretax margin	22.04%
Profit margin	17.49%
Profit per employee	EUR 117,360
Profitable quarters	106
Profitable years	28
Revenue per employee	EUR 671,141
ROA	10.86%
ROA (5Y)	7.4%
ROCE	23.04%
ROE	24.33%
ROE (5Y)	23.91%
ROIC	19.26%
ROIC (5Y)	17.5%
SBC / revenue	1.98%
Tax / revenue	4.58%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-28.31%
EPS growth (Q)	-68.81%
EPS growth (QoQ)	-63.16%
EPS growth 10Y	6.32%
EPS growth 3Y	12.03%
EPS growth 5Y	3.87%
EPS growth years	1
FCF growth	-20.02%
FCF growth (Q)	-17.79%
FCF growth (QoQ)	-8.09%
FCF growth 3Y	1.3%
FCF growth 5Y	2.63%
Gross profit growth	0.4%
Gross profit growth (Q)	5.89%
Gross profit growth 3Y	8.64%
Gross profit growth 5Y	3.12%
Net income growth	-30.31%
Net income growth (Q)	-69.4%
Net income growth (QoQ)	-63.17%
Net income growth 3Y	8.58%
Net income growth 5Y	0.45%
Net income growth years	1
OCF growth	-17.79%
OCF growth (Q)	-16.25%
OCF growth (QoQ)	-6.44%
OCF growth 10Y	3.71%
OCF growth 3Y	2.64%
OCF growth 5Y	2.66%
Operating income growth	1.26%
Operating income growth (Q)	16.25%
Operating income growth 3Y	19.41%
Operating income growth 5Y	7.48%
Revenue growth	1.76%
Revenue growth (Q)	4.67%
Revenue growth (QoQ)	0.52%
Revenue growth 10Y	1.46%
Revenue growth 3Y	7.75%
Revenue growth 5Y	1.83%
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -1.5B
Depreciation and amortization	EUR 4.1B
EBIT	EUR 17.2B
EBITDA	EUR 21.2B
EPS	EUR 4.72
Financing cash flow	EUR 685.1M
Free cash flow	EUR 13.8B
Free cash flow minus SBC	EUR 12.8B
Gross profit	EUR 38B
Income taxes	EUR 2.3B
Investing cash flow	EUR -16.5B
Net borrowing	EUR 14.5B
Net cash flow	EUR -604.1M
Net income	EUR 8.8B
Operating cash flow minus SBC	EUR 14.3B
Operating income	EUR 17.2B
Revenue	EUR 50.5B
Stock-based compensation	EUR 1B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.56
Book value per share	EUR 17.36
Debt / EBITDA	1.98
Debt / equity	1.29
Debt / FCF	3.09
Goodwill	EUR 24.4B
Interest coverage	12.36
Long-term assets	EUR 77.4B
Long-term liabilities	EUR 40.9B
Net cash (debt)	EUR -34.7B
Net cash / market cap	-13.16%
Net debt / EBITDA	1.64
Net debt / equity	1.05
Net debt / FCF	2.52
Piotroski F-Score	5
Property, plant and equipment	EUR 11B
Shareholders' equity	EUR 33.1B
Tangible book value	EUR -26.2B
Tangible book value per share	EUR -13.88
Total assets	EUR 103.2B
Total cash	EUR 7.8B
Total debt	EUR 42.5B
Total liabilities	EUR 70.1B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.51
Current assets	EUR 25.8B
Current liabilities	EUR 29.2B
Current ratio	0.88
Inventory turnover	2.27
Net working capital	EUR -2.4B
Quick ratio	0.58
Working capital	EUR -3.3B
Working capital turnover	-13.33

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	2.76%
Dividend growth	12.84%
Dividend growth (10Y)	5.15%
Dividend growth (3Y)	8.16%
Dividend growth (5Y)	8.63%
Dividend growth years	4
Dividend payment date	2026-03-12
Dividend payment years	27
Dividend payout frequency	Annual
Dividend per share	EUR 4.10
Dividend yield	2.94%
Ex-dividend date	2026-03-10
Last dividend	EUR 4.10
Payout ratio	90.4%
Shareholder yield	5.69%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	112.86%
10Y return CAGR	11.91%
10Y total return	208.08%
150-day SMA	EUR 130.74
15Y price change	241.51%
15Y return CAGR	12.58%
15Y total return	491.27%
1D price change	-0.31%
1M price change	10.39%
1M total return	10.39%
1W price change	2.58%
1W total return	2.58%
1Y price change	25.63%
1Y return CAGR	29.73%
1Y total return	29.71%
20-day SMA	EUR 132.11
200-day SMA	EUR 131.27
20Y price change	192.09%
20Y return CAGR	9.44%
20Y total return	507.75%
3M price change	1.08%
3M total return	1.08%
50-day SMA	EUR 129.96
50-day SMA vs 200-day SMA	50under200
52-week high	EUR 144.12
52-week high date	2026-02-27
52-week low	EUR 104.52
52-week low date	2025-10-29
6M price change	12.9%
6M total return	12.9%
All-time high	EUR 1,945.00
All-time high date	2001-01-04
All-time low	EUR 26.41
All-time low date	2009-03-04
Average true range (ATR)	EUR 2.62
Average volume	5.3K
Change from 52-week high	-3.16%
Change from 52-week low	33.53%
Change from all-time high	-92.8%
Change from all-time low	430.1%
Change from open	-0.39%
Day's gap	0.07%
Dollar volume	EUR 819,636
High price	EUR 141.48
Low price	EUR 138.94
Monthly RSI	67.83
Open price	EUR 140.10
Position in 52-week range	24.41%
Previous close	EUR 140.00
Price vs 150-day SMA	7.08%
Price vs 20-day SMA	5.98%
Price vs 200-day SMA	6.65%
Price vs 50-day SMA	7.73%
Relative volume	1.11
RSI	65.5
Sharpe ratio	1.24
Sharpe ratio (3Y)	1.11
Sharpe ratio (5Y)	0.71
Sortino ratio	1.93
Sortino ratio (3Y)	2.61
Sortino ratio (5Y)	1.64
Volume	5.9K
Weekly RSI	58.33
YTD price change	18.4%
YTD total return	22.25%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.9B
Shares change (QoQ)	-0.47%
Shares change (YoY)	-2.76%
Shares held by insiders	0.11%
Shares held by institutions	36.29%

Deeper analysis on ETR/NOT

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ETR/NOT report

Is a complete ETR/NOT research report available?

No complete published report is available for etr/NOT (ETR/NOT) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ETR/NOT (ETR/NOT)

Price

Financial snapshot

Fair-value bridge

Latest news · ETR/NOT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ETR/NOT indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ETR/NOT

Frequently asked questions